Postnatal Age Is a Critical Determinant of the Neonatal Host Response to Sepsis

Neonates manifest a unique host response to sepsis even among other children. Preterm neonates may experience sepsis soon after birth or during often-protracted birth hospitalizations as they attain physiologic maturity. We examined the transcriptome using genome-wide expression profiling on prospectively collected peripheral blood samples from infants evaluated for sepsis within 24 h after clinical presentation. Simultaneous plasma samples were examined for alterations in inflammatory mediators. Group designation (sepsis or uninfected) was determined retrospectively on the basis of clinical exam and laboratory results over the next 72 h from the time of evaluation. Unsupervised analysis showed the major node of separation between groups was timing of sepsis episode relative to birth (early, <3 d, or late, ≥3 d). Principal component analyses revealed significant differences between patients with early or late sepsis despite the presence of similar key immunologic pathway aberrations in both groups. Unique to neonates, the uninfected state and host response to sepsis is significantly affected by timing relative to birth. Future therapeutic approaches may need to be tailored to the timing of the infectious event based on postnatal age.

[1]  C. Lindsell,et al.  Developing a clinically feasible personalized medicine approach to pediatric septic shock. , 2015, American journal of respiratory and critical care medicine.

[2]  R. Xavier,et al.  mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity , 2014, Science.

[3]  R. Xavier,et al.  Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity , 2014, Science.

[4]  L. Saiman,et al.  Time for a Neonatal-Specific Consensus Definition for Sepsis , 2014, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[5]  J. Rebel,et al.  Early-Life Environmental Variation Affects Intestinal Microbiota and Immune Development in New-Born Piglets , 2014, PloS one.

[6]  G. Pérez-Martínez,et al.  Genome-Wide Expression Profiles in Very Low Birth Weight Infants With Neonatal Sepsis , 2014, Pediatrics.

[7]  H. Wong,et al.  Gene expression profiling in sepsis: timing, tissue, and translational considerations. , 2014, Trends in molecular medicine.

[8]  D. Aliefendioğlu,et al.  Can resistin be a new indicator of neonatal sepsis? , 2014, Pediatrics and neonatology.

[9]  C. Garlanda,et al.  The interleukin-1 family: back to the future. , 2013, Immunity.

[10]  D. Angus,et al.  Trends in the Epidemiology of Pediatric Severe Sepsis* , 2013, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[11]  A. Karlsson,et al.  The Human Neutrophil Subsets Defined by the Presence or Absence of OLFM4 Both Transmigrate into Tissue In Vivo and Give Rise to Distinct NETs In Vitro , 2013, PloS one.

[12]  T. Miyakawa,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013 .

[13]  R. Gamelli,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013, Proceedings of the National Academy of Sciences.

[14]  R. Tompkins,et al.  Development of a Genomic Metric That Can Be Rapidly Used to Predict Clinical Outcome in Severely Injured Trauma Patients* , 2013, Critical care medicine.

[15]  B. Stoll,et al.  Blood stream infection is associated with altered heptavalent pneumococcal conjugate vaccine immune responses in very low birth weight infants , 2013, Journal of Perinatology.

[16]  H. Wong.  Genome-wide expression profiling in pediatric septic shock , 2013, Pediatric Research.

[17]  T. Fleisher.  Treatment of Neonatal Sepsis With Intravenous Immune Globulin , 2012, Pediatrics.

[18]  P. Smith,et al.  Use of the Complete Blood Cell Count in Late-onset Neonatal Sepsis , 2012, The Pediatric infectious disease journal.

[19]  P. Smith,et al.  Use of the Complete Blood Cell Count in Early-onset Neonatal Sepsis , 2012, The Pediatric infectious disease journal.

[20]  A. Silahtaroglu,et al.  Olfactomedin 4 defines a subset of human neutrophils , 2012, Journal of leukocyte biology.

[21]  H. Wong,et al.  A novel role for matrix metalloproteinase-8 in sepsis* , 2012, Critical care medicine.

[22]  Sue E. Poynter,et al.  Validation of a gene expression-based subclassification strategy for pediatric septic shock* , 2011, Critical care medicine.

[23]  John D. Storey,et al.  Human transcriptome array for high-throughput clinical studies , 2011, Proceedings of the National Academy of Sciences.

[24]  S. Flohe,et al.  Increased serum soluble Fas after major trauma is associated with delayed neutrophil apoptosis and development of sepsis , 2011, Critical care.

[25]  B. Poindexter,et al.  Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network , 2010, Pediatrics.

[26]  J. Sung,et al.  Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. , 2010, The Journal of clinical investigation.

[27]  Derek S. Wheeler,et al.  The Host Response to Sepsis and Developmental Impact , 2010, Pediatrics.

[28]  H. Wong,et al.  Leukocyte subset-derived genomewide expression profiles in pediatric septic shock* , 2009, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[29]  Kuang-Yu Liu,et al.  Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and CD16- monocyte subsets , 2009, BMC Genomics.

[30]  J. Neu,et al.  Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis , 2009, Journal of Perinatology.

[31]  Thomas P. Shanley,et al.  Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum* , 2009, Critical care medicine.

[32]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[33]  H. Wong,et al.  Divergence of canonical danger signals: The genome-level expression patterns of human mononuclear cells subjected to heat shock or lipopolysaccharide , 2008, BMC Immunology.

[34]  W. Ollier,et al.  Successful downstream application of the Paxgene Blood RNA system from small blood samples in paediatric patients for quantitative PCR analysis , 2007, BMC Immunology.

[35]  Michael G. Barnes,et al.  Genome-Level Longitudinal Expression of Signaling Pathways and Gene Networks in Pediatric Septic Shock , 2007, Molecular medicine.

[36]  Michael G. Barnes,et al.  Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. , 2007, Physiological genomics.

[37]  Martin L. Lee,et al.  Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock , 2007, Critical care medicine.

[38]  A. Spitzer,et al.  Reported Medication Use in the Neonatal Intensive Care Unit: Data From a Large National Data Set , 2006, Pediatrics.

[39]  B. Vohr,et al.  Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. , 2004, JAMA.

[40]  F. Taylor,et al.  Reduced Neutrophil CD10 Expression in Nonhuman Primates and Humans After In Vivo Challenge with E. coli or Lipopolysaccharide , 2003, Shock.

[41]  W. Poole,et al.  Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. , 2002, Pediatrics.

[42]  K. Puopolo.  Treatment of Neonatal Sepsis with Intravenous Immune Globulin , 2012 .

[43]  Michael T. Bigham,et al.  The Influence of Developmental Age on the Early Transcriptomic Response of Children with Septic Shock , 2011, Molecular medicine.

[44]  Robert J Freishtat,et al.  BMC Medicine BioMed Central , 2009 .

[45]  J. Neu,et al.  Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis , 2009, Journal of Perinatology.

[46]  William Oh,et al.  Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants , 2003 .

[47]  P. Ghazal,et al.  Edinburgh Research Explorer Identification of a human neonatal immune-metabolic network associated with bacterial infection , 2022 .